Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease

被引:71
|
作者
Aridogan, BC
Yildirim, M
Baysal, V
Inaloz, HS
Baz, K
Kaya, S
机构
[1] Univ Suleyman Demirel, Fac Med, Dept Microbiol & Clin Microbiol, Isparta, Turkey
[2] Univ Gaziantep, Fac Med, Dept Dermatol, Gaziantep, Turkey
[3] Univ Mersin, Fac Med, Dept Dermatol, Mersin, Turkey
来源
JOURNAL OF DERMATOLOGY | 2003年 / 30卷 / 08期
关键词
Behcet's disease; recurrent aphthous stomatitis; cytokines; Th1; Th2;
D O I
10.1111/j.1346-8138.2003.tb00442.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Behcet's disease (BD) is an inflammatory disease of unknown etiology. Although its pathogenesis is not fully understood, recent studies have suggested that immunological abnormalities and neutrophil hyperfunction may be involved in its etiology and pathophysiology. The immune system in BD can be characterized as a divergent cytokine production profile of the mixed Th1/Th2 cell type. In this study, we investigated the levels of interleukin (IL)-4, IL-10, IL-12, IL-13 and interferon-gamma in the sera of patients with BD, III comparison with recurrent aphthous stomatitis and healthy controls, to determine the Th1/Th2 profile of the disease. The levels of IL-4, IL-10 and IL-13 were found to be high in active BD patients, and IL-12 and interferon-gamma levels were lower In active BD patients than in inactive BD, recurrent aphthous stomatitis, and control patients.
引用
收藏
页码:602 / 607
页数:6
相关论文
共 50 条
  • [31] IL-4, IL-13 and IL-10 induce monocyte apoptosis in patients with inflammatory bowel disease by different pathways
    Kucharzik, T
    Schmidt, M
    Lugering, N
    Pauels, HG
    Domschke, W
    GASTROENTEROLOGY, 1999, 116 (04) : A754 - A754
  • [32] Polymorphisms of IL-4, IL-10 and IL-13 genes in Polish population of atopic dermatitis patients
    Narbutt, J.
    Przybylowska, K.
    Kuna, P.
    Stelmach, I
    Slowik-Rylska, M.
    Lesiak, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S11 - S11
  • [33] IFN Gamma Modulation by IL 18, IL 4 and IL 10 During Behcet Disease Evolution
    Belguendouz, H.
    Messaoudene, D.
    Ahmedi, M. L.
    Lahmar, K.
    Ider, F. Z.
    Medjber, O.
    Hartani, D.
    Touil-Boukoffa, C.
    PROCEEDINGS OF THE 7TH JOINT MEETING OF THE INTERNATIONAL MEETING OF THE INTERNATIONAL CYTOKINE SOCIETY AND THE INTERNATIONAL SOCIETY FOR INTERFERON AND CYTOKINE RESEARCH, 2008, : 9 - 13
  • [34] Monocytic secretion of lysosomal enzymes in patients with inflammatory bowel disease - Modulation by IL-13, IL-4 and IL-10
    Lugering, N
    Kucharzik, T
    Winde, G
    Domschke, W
    Stoll, R
    GUT, 1997, 41 : A116 - A117
  • [35] DOWN-REGULATING EFFECTS OF IL-4 AND IL-10 ON THE IFN-GAMMA RESPONSE IN ATOPIC-DERMATITIS
    LESTER, MR
    HOFER, MF
    GATELY, M
    TRUMBLE, A
    LEUNG, DYM
    JOURNAL OF IMMUNOLOGY, 1995, 154 (11): : 6174 - 6181
  • [36] Interleukin (IL)-4, IL-10 and IL-12 profile in serum of patients with alveolar echinococcosis
    Wellinghausen, N
    Gebert, P
    Kern, P
    ACTA TROPICA, 1999, 73 (02) : 165 - 174
  • [37] IL-12, IL-4 and IFN gamma in the induction of experimental autoimmune uveitis.
    Trammell, RA
    Moticka, EJ
    FASEB JOURNAL, 1996, 10 (06): : 2035 - 2035
  • [38] Increased Levels of IL-10, IL-12, and IFN-γ in Patients with Visceral Leishmaniasis
    Khoshdel, A.
    Alborzi, A.
    Rosouli, M.
    Taheri, E.
    Kiany, S.
    Javadian, M. H.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (01): : 44 - 46
  • [39] Reduced skin blistering in experimental epidermolysis bullosa after blockade of IFN-gamma or administration of IL-4/IL-13
    Scheppan, D.
    Markton, J. T.
    Ludwig, R. J.
    Bieber, K.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E80 - E81
  • [40] IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer
    Riemensberger, J
    Böhle, A
    Brandau, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01): : 20 - 26